Brodsky RA, Peffault de Latour R, Rottinghaus ST, Roth A, et al. Characterization of breakthrough hemolysis events observed in the phase 3 randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria. Haematologica 2021;106:230-237.
PMID: 31949012